TABLE 5.
Performance of IgG against panels of recombinant antigensa
Model | % Error rate (no. of positive samples/total no. of samples) | % Sensitivity (no. of positive samples/total no. of samples) | % Specificity (no. of positive samples/total no. of samples) |
---|---|---|---|
Full model (with 15 predictors) | 3.7 (3/82)* | 96.6 (57/59)* | 95.6 (22/23)* |
SET1, ENO1, FBA1, PGK1-1, PGK1-2, MUC1-2, BGL21 | 3.7 (3/82)* | 96.6 (57/59)* | 95.6 (22/23)* |
SET1, ENO1, PGK1-2, MUC1-2 | 3.7 (3/82)* | 96.6 (57/59)* | 95.6 (22/23)* |
SET1, ENO1, MUC1-2 | 4.8 (4/84) | 95.0 (57/60) | 95.8 (23/24) |
* indicates that one patient with systemic candidiasis and one control did not have sufficient sera to test against PGK1-1 and PGK1-2.